National Chapter Vision Webinar: Update on Emerging Therapies

The webinar will provide reviews of several treatments in the clinical development pipeline including AGTC’s gene therapy clinical trials for X-linked retinitis pigmentosa and achromatopsia; SparingVision’s emerging cone-saving and cone-restoring treatments for retinitis pigmentosa, Usher syndrome, and related conditions; gene-agnostic approaches for a variety of conditions, clinical trials underway for Stargardt disease, and new emerging gene therapies for Leber congenital amaurosis.

Presenters will include: 

• Daniel Chung, DO, Chief Medical Officer, SparingVision
• Bright Ashimatey, OD, PhD, FAAO, Clinical Research Scientist, AGTC
• Claire Gelfman, PhD, Chief Scientific Officer, Foundation Fighting Blindness
• Ben Shaberman, Senior Director, Scientific Outreach, Foundation Fighting Blindness